{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:34:35Z","timestamp":1776285275888,"version":"3.50.1"},"reference-count":86,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The present work aims at establishing multi-target chemometric models using the recently launched quantitative structure\u2013activity relationship (QSAR)-Co tool for predicting the activity of inhibitor compounds against different isoforms of phosphoinositide 3-kinase (PI3K) under various experimental conditions. The inhibitors of class I phosphoinositide 3-kinase (PI3K) isoforms have emerged as potential therapeutic agents for the treatment of various disorders, especially cancer. The cell-based enzyme inhibition assay results of PI3K inhibitors were curated from the CHEMBL database. Factors such as the nature and mutation of cell lines that may significantly alter the assay outcomes were considered as important experimental elements for mt-QSAR model development. The models, in turn, were developed using two machine learning techniques as implemented in QSAR-Co: linear discriminant analysis (LDA) and random forest (RF). Both techniques led to models with high accuracy (ca. 90%). Several molecular fragments were extracted from the current dataset, and their quantitative contributions to the inhibitory activity against all the proteins and experimental conditions under study were calculated. This case study also demonstrates the utility of QSAR-Co tool in solving multi-factorial and complex chemometric problems. Additionally, the combination of different in silico methods employed in this work can serve as a valuable guideline to speed up early discovery of PI3K inhibitors.<\/jats:p>","DOI":"10.3390\/ijms20174191","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T11:13:30Z","timestamp":1566904410000},"page":"4191","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Development of Multi-Target Chemometric Models for the Inhibition of Class I PI3K Enzyme Isoforms: A Case Study Using QSAR-Co Tool"],"prefix":"10.3390","volume":"20","author":[{"given":"Amit Kumar","family":"Halder","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry, University of Porto, 4169-007 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3375-8670","authenticated-orcid":false,"given":"M. Nat\u00e1lia Dias Soeiro","family":"Cordeiro","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, University of Porto, 4169-007 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrd1608","article-title":"Data integration: Challenges for drug discovery","volume":"4","author":"Searls","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.drudis.2018.05.010","article-title":"Machine learning in chemoinformatics and drug discovery","volume":"23","author":"Lo","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sun, G.H., Fan, T.J., Zhang, N., Ren, T., Zhao, L.J., and Zhong, R.G. (2016). Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking. Molecules, 21.","DOI":"10.3390\/molecules21070823"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Fan, T.J., Sun, G.H., Zhao, L.J., Cui, X., and Zhong, R.G. (2018). QSAR and Classification Study on Prediction of Acute Oral Toxicity of N-Nitroso Compounds. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103015"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Sun, G.H., Fan, T.J., Sun, X.D., Hao, Y.X., Cui, X., Zhao, L.J., Ren, T., Zhou, Y., Zhong, R.G., and Peng, Y.Z. (2018). In Silico Prediction of O-6-Methylguanine-DNA Methyltransferase Inhibitory Potency of Base Analogs with QSAR and Machine Learning Methods. Molecules, 23.","DOI":"10.3390\/molecules23112892"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.4155\/fmc-2018-0213","article-title":"Recent advances in fragment-based computational drug design: Tackling simultaneous targets\/biological effects","volume":"10","year":"2018","journal-title":"Future Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2174\/092986712799945058","article-title":"Role of Ligand-Based Drug Design Methodologies toward the Discovery of New Anti-Alzheimer Agents: Futures Perspectives in Fragment-Based Ligand Design","volume":"19","author":"Luan","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1016\/j.bmc.2011.09.015","article-title":"Multi-target drug discovery in anti-cancer therapy: Fragment-based approach toward the design of potent and versatile anti-prostate cancer agents","volume":"19","author":"Kleandrova","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1016\/j.ejmech.2011.09.055","article-title":"Fragment-based QSAR model toward the selection of versatile anti-sarcoma leads","volume":"46","author":"Kleandrova","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Speck-Planche, A., and Cordeiro, M.N.D.S. (2017). Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins. Mol. Divers., 21.","DOI":"10.1007\/s11030-017-9731-1"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1021\/acs.jcim.9b00295","article-title":"QSAR-Co: An Open Source Software for Developing Robust Multitasking or Multitarget Classification-Based QSAR Models","volume":"59","author":"Ambure","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.molcel.2018.08.005","article-title":"Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human Disease","volume":"71","author":"Burke","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR Signaling in Cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_14","first-page":"165","article-title":"Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer","volume":"4","author":"Yip","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Miller, M.S., Thompson, P.E., and Gabelli, S.B. (2019). Structural Determinants of Isoform Selectivity in PI3K Inhibitors. Biomolecules, 9.","DOI":"10.3390\/biom9030082"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"13541","DOI":"10.1074\/jbc.M116.772426","article-title":"Kinetic and structural analyses reveal residues in phosphoinositide 3-kinase alpha that are critical for catalysis and substrate recognition","volume":"292","author":"Maheshwari","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbcan.2019.03.003","article-title":"Targeting PI3K signaling in cancer: Challenges and advances","volume":"1871","author":"Gulluni","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: Divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"15","author":"Thorpe","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Piddock, R.E., Bowles, K.M., and Rushworth, S.A. (2017). The Role of PI3K Isoforms in Regulating Bone Marrow Microenvironment Signaling Focusing on Acute Myeloid Leukemia and Multiple Myeloma. Cancers, 9.","DOI":"10.3390\/cancers9040029"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nm1232","article-title":"PI 3-kinase p110beta: A new target for antithrombotic therapy","volume":"11","author":"Jackson","year":"2005","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8559","DOI":"10.1021\/jm300847w","article-title":"PI3Kdelta and PI3Kgamma as targets for autoimmune and inflammatory diseases","volume":"55","author":"Cushing","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1165\/rcmb.2016-0308TR","article-title":"Phosphoinositide 3-Kinase in Asthma: Novel Roles and Therapeutic Approaches","volume":"56","author":"Yoo","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: Mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1158\/1078-0432.CCR-14-2522","article-title":"FDA approval: Idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma","volume":"21","author":"Miller","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Sanchez, V.E., Nichols, C., Kim, H.N., Gang, E.J., and Kim, Y.M. (2019). Targeting PI3K Signaling in Acute Lymphoblastic Leukemia. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020412"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K Pathway in Human Disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1073\/pnas.0802655105","article-title":"PTEN-deficient cancers depend on PIK3CB","volume":"105","author":"Wee","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40264-018-0778-4","article-title":"Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in Oncology","volume":"42","author":"Curigliano","year":"2019","journal-title":"Drug Saf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1021\/acsmedchemlett.6b00238","article-title":"Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-gamma Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate","volume":"7","author":"Evans","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_31","first-page":"821","article-title":"PI3K Inhibitors: Understanding Toxicity Mechanisms and Management","volume":"31","author":"Greenwell","year":"2017","journal-title":"Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s00044-012-0081-3","article-title":"QSAR and pharmacophore modeling of N-acetyl-2-aminobenzothiazole class of phosphoinositide-3-kinase-alpha inhibitors","volume":"22","author":"Bharate","year":"2013","journal-title":"Med. Chem. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/1062936X.2014.883428","article-title":"Imidazo[1,2-a]pyrazine inhibitors of phosphoinositide 3-kinase alpha (PI3K alpha): 3D-QSAR analysis utilizing the Hybrid Monte Carlo algorithm to refine receptor-ligand complexes for molecular alignment","volume":"25","author":"Chadha","year":"2014","journal-title":"Sar Qsar Env. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/1062936X.2016.1209555","article-title":"Identification of new dual spleen tyrosine kinase (Syk) and phosphoionositide-3-kinase (PI3K) inhibitors using ligand and structure-based integrated ideal pharmacophore models","volume":"27","author":"Kaur","year":"2016","journal-title":"Sar Qsar Env. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00894-010-0659-y","article-title":"Pharmacophore modeling and 3D-QSAR analysis of phosphoinositide 3-kinase p110alpha inhibitors","volume":"16","author":"Li","year":"2010","journal-title":"J. Mol. Model."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10822-010-9321-0","article-title":"Consensus model for identification of novel PI3K inhibitors in large chemical library","volume":"24","author":"Liew","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/1386207320666170427143858","article-title":"3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K\/mTOR Inhibitors with Enhanced Antiproliferative Activity","volume":"20","author":"Oluic","year":"2017","journal-title":"Comb. Chem. High. Throughput Screen."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s11224-018-1154-9","article-title":"Discovery and design of new PI3K inhibitors through pharmacophore-based virtual screening, molecular docking, and binding free energy analysis","volume":"29","author":"Peddi","year":"2018","journal-title":"Struct. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"56344","DOI":"10.1039\/C7RA10870B","article-title":"Molecular modeling studies of quinazolinone derivatives as novel PI3K delta selective inhibitors","volume":"7","author":"Peng","year":"2017","journal-title":"RSC Adv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00894-011-1034-3","article-title":"A selectivity study on mTOR\/PI3Kalpha inhibitors by homology modeling and 3D-QSAR","volume":"18","author":"Ran","year":"2012","journal-title":"J. Mol. Model."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00044-012-0151-6","article-title":"Quasi 4D-QSAR and 3D-QSAR study of the pan class I phosphoinositide-3-kinase (PI3K) inhibitors","volume":"22","author":"Ghasemi","year":"2013","journal-title":"Med. Chem. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2174\/1568009617666170330152617","article-title":"In-silico & In-vitro Identification of Structure-Activity Relationship Pattern of Serpentine & Gallic Acid Targeting PI3Kgamma as Potential Anticancer Target","volume":"17","author":"Sharma","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ejmech.2014.07.056","article-title":"Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3K gamma) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis","volume":"84","author":"Taha","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10822-016-9905-4","article-title":"Structural insights of a PI3K\/mTOR dual inhibitor with the morpholino-triazine scaffold","volume":"30","author":"Takeda","year":"2016","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/08927022.2012.751592","article-title":"Pharmacophore models generation by catalyst and phase consensus-based virtual screening protocol against PI3K alpha inhibitors","volume":"39","author":"Wang","year":"2013","journal-title":"Mol. Simul."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s00894-011-1299-6","article-title":"Molecular simulation of a series of benzothiazole PI3Kalpha inhibitors: Probing the relationship between structural features, anti-tumor potency and selectivity","volume":"18","author":"Wang","year":"2012","journal-title":"J. Mol. Model."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1039\/c3md00157a","article-title":"Exploring the selectivity of PI3K alpha and mTOR inhibitors by 3D-QSAR, molecular dynamics simulations and MM\/GBSA binding free energy decomposition","volume":"4","author":"Wu","year":"2013","journal-title":"Medchemcomm"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molstruc.2013.09.049","article-title":"3D-QSAR and docking studies of 3-Pyridine heterocyclic derivatives as potent PI3K\/mTOR inhibitors","volume":"1054","author":"Yang","year":"2013","journal-title":"J. Mol. Struct."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10822-017-0092-8","article-title":"Discovering new PI3K alpha inhibitors with a strategy of combining ligand-based and structure-based virtual screening","volume":"32","author":"Yu","year":"2018","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00044-017-1936-4","article-title":"De novo computational design of compounds virtually displaying potent antibacterial activity and desirable in vitro ADMET profiles","volume":"26","author":"Cordeiro","year":"2017","journal-title":"Med. Chem. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/ci00020a020","article-title":"Application of Genetic Function Approximation to Quantitative Structure-Activity-Relationships and Quantitative Structure-Property Relationships","volume":"34","author":"Rogers","year":"1994","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"ref_52","unstructured":"Snedecor, G.W., and Cochran, W.G. (1989). Statistical methods, Iowa State University Press. [8th ed.]."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chemolab.2015.07.007","article-title":"\u201cNanoBRIDGES\u201d software: Open access tools to perform QSAR and nano-QSAR modeling","volume":"147","author":"Ambure","year":"2015","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10822-015-9860-5","article-title":"Activity, assay and target data curation and quality in the ChEMBL database","volume":"29","author":"Papadatos","year":"2015","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.chembiol.2003.09.002","article-title":"The process of structure-based drug design","volume":"10","author":"Anderson","year":"2003","journal-title":"Chem. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/biomet\/24.3-4.471","article-title":"Certain generalizations in the analysis of variance","volume":"24","author":"Wilks","year":"1932","journal-title":"Biometrika"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Boughorbel, S., Jarray, F., and El-Anbari, M. (2017). Optimal classifier for imbalanced data using Matthews Correlation Coefficient metric. PloS ONE, 12.","DOI":"10.1371\/journal.pone.0177678"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/bioinformatics\/btq037","article-title":"Small-sample precision of ROC-related estimates","volume":"26","author":"Hanczar","year":"2010","journal-title":"Bioinformatics"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/ci700157b","article-title":"y-Randomization and its variants in QSPR\/QSAR","volume":"47","author":"Rucker","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"10649","DOI":"10.1021\/acssuschemeng.9b01306","article-title":"Probing the Environmental Toxicity of Deep Eutectic Solvents and Their Components: An In Silico Modeling Approach","volume":"7","author":"Halder","year":"2019","journal-title":"Acs Sustain. Chem. Eng."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.chemolab.2015.04.013","article-title":"On a simple approach for determining applicability domain of QSAR models","volume":"145","author":"Roy","year":"2015","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1021\/ci0155053","article-title":"Structure\/Response Correlations and Similarity\/Diversity Analysis by GETAWAY Descriptors. 2. Application of the Novel 3D Molecular Descriptors to QSAR\/QSPR Studies","volume":"42","author":"Consonni","year":"2002","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1021\/ci015504a","article-title":"Structure\/Response Correlations and Similarity\/Diversity Analysis by GETAWAY Descriptors. 1. Theory of the Novel 3D Molecular Descriptors","volume":"42","author":"Consonni","year":"2002","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"ref_64","unstructured":"Todeschini, R., Consonni, V., Mannhold, R., Kubinyi, H., Folkers, G., and Wiley Online Library (2010). Molecular Descriptors for Chemoinformatics. Vol. I & II. Methods and Principles in Medicinal Chemistry Ser 82, Wiley-VCH Imprint. John Wiley & Sons, Incorporated. p 1 online resource."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Consonni, V., Todeschini, R., and Wiley Online Library (2000). Handbook of molecular descriptors. Methods and principles in medicinal chemistry 11, Wiley-VCH. p 1 online resource.","DOI":"10.1002\/9783527613106"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1021\/ci950186z","article-title":"Edge adjacency relationships and molecular topographic descriptors. Definition and QSAR applications","volume":"36","author":"Estrada","year":"1996","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jmgm.2014.10.006","article-title":"3D-MoRSE descriptors explained","volume":"54","author":"Devinyak","year":"2014","journal-title":"J. Mol. Graph. Model."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/21642583.2014.956265","article-title":"Random forests: From early developments to recent advancements","volume":"2","author":"Fawagreh","year":"2014","journal-title":"Syst. Sci. Control. Eng."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.chemolab.2015.09.011","article-title":"QSAR models and scaffold-based analysis of non-nucleoside HIV RT inhibitors","volume":"148","author":"Nizami","year":"2015","journal-title":"Chemom. Intell Lab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/1062936X.2018.1529702","article-title":"Finding the structural requirements of diverse HIV-1 protease inhibitors using multiple QSAR modelling for lead identification","volume":"29","author":"Halder","year":"2018","journal-title":"Sar Qsar Env. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1021\/acs.jcim.6b00753","article-title":"Comparison of the Predictive Performance and Interpretability of Random Forest and Linear Models on Benchmark Data Sets","volume":"57","author":"Palczewska","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10822-008-9240-5","article-title":"On the interpretation and interpretability of quantitative structure-activity relationship models","volume":"22","author":"Guha","year":"2008","journal-title":"J. Comput. Aid. Mol. Des."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1214\/07-EJS039","article-title":"Variable importance in binary regression trees and forests","volume":"1","author":"Ishwaran","year":"2007","journal-title":"Electron. J. Stat."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Nawar, S., and Mouazen, A.M. (2017). Comparison between Random Forests, Artificial Neural Networks and Gradient Boosted Machines Methods of On-Line Vis-NIR Spectroscopy Measurements of Soil Total Nitrogen and Total Carbon. Sensors, 17.","DOI":"10.3390\/s17102428"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Lee, K., Lee, M., and Kim, D. (2017). Utilizing random Forest QSAR models with optimized parameters for target identification and its application to target-fishing server. BMC Bioinform., 18.","DOI":"10.1186\/s12859-017-1960-x"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/jm9602928","article-title":"The properties of known drugs. 1. Molecular frameworks","volume":"39","author":"Bemis","year":"1996","journal-title":"J. Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10822-011-9440-2","article-title":"Online chemical modeling environment (OCHEM): Web platform for data storage, model development and publishing of chemical information","volume":"25","author":"Sushko","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/ci00020a039","article-title":"Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures","volume":"34","author":"Sadowski","year":"1994","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/ci400716y","article-title":"ANN multiscale model of anti-HIV drugs activity vs AIDS prevalence in the US at county level based on information indices of molecular graphs and social networks","volume":"54","author":"Munteanu","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1021\/cn400111n","article-title":"Model for high-throughput screening of multitarget drugs in chemical neurosciences: Synthesis, assay, and theoretic study of rasagiline carbamates","volume":"4","author":"Alonso","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Speck-Planche, A., and Scotti, M.T. (2018). BET bromodomain inhibitors: Fragment-based in silico design using multi-target QSAR models. Mol. Divers.","DOI":"10.1007\/s11030-018-9890-8"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Tinsley, H.E.A., and Brown, S.D. (2000). 11 - Cluster Analysis. Handbook of Applied Multivariate Statistics and Mathematical Modeling, Academic Press.","DOI":"10.1016\/B978-012691360-6\/50002-1"},{"key":"ref_84","unstructured":"Statsoft-Team (2001) STATISTICA (2019, May 22). Data analysis software system. v6.0, Tulsa. Available online: http:\/\/www.statsoft.com\/Products\/STATISTICA-Features."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Tinsley, H.E.A., and Brown, S.D. (2000). 8 - Discriminant Analysis. Handbook of Applied Multivariate Statistics and Mathematical Modeling, Academic Press.","DOI":"10.1016\/B978-012691360-6\/50002-1"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"14704","DOI":"10.1021\/acsomega.8b02419","article-title":"Combining Ensemble Learning with a Fragment-Based Topological Approach To Generate New Molecular Diversity in Drug Discovery: In Silico Design of Hsp90 Inhibitors","volume":"3","year":"2018","journal-title":"Acs Omega"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/17\/4191\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:14:14Z","timestamp":1760188454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/17\/4191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":86,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["ijms20174191"],"URL":"https:\/\/doi.org\/10.3390\/ijms20174191","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]}}}